MiniMed Group Statistics
Total Valuation
MiniMed Group has a market cap or net worth of $7.44 billion. The enterprise value is $7.43 billion.
| Market Cap | 7.44B |
| Enterprise Value | 7.43B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
MiniMed Group has 280.81 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 280.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.58 |
| Forward PS | n/a |
| PB Ratio | 2.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 531.54 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.58 |
| EV / EBITDA | 256.33 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 1.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -5.51% and return on invested capital (ROIC) is -3.46%.
| Return on Equity (ROE) | -5.51% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.46% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $360,750 |
| Profits Per Employee | -$26,375 |
| Employee Count | 8,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MiniMed Group has paid $72.00 million in taxes.
| Income Tax | 72.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MiniMed Group had revenue of $2.89 billion and -$211.00 million in losses. Loss per share was -$0.75.
| Revenue | 2.89B |
| Gross Profit | 1.64B |
| Operating Income | -123.00M |
| Pretax Income | -139.00M |
| Net Income | -211.00M |
| EBITDA | 29.00M |
| EBIT | -124.00M |
| Loss Per Share | -$0.75 |
Full Income StatementBalance Sheet
The company has $8.00 million in cash and n/a in debt, with a net cash position of $8.00 million or $0.03 per share.
| Cash & Cash Equivalents | 8.00M |
| Total Debt | n/a |
| Net Cash | 8.00M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 3.56B |
| Book Value Per Share | 12.68 |
| Working Capital | 431.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $14.00 million and capital expenditures -$221.00 million, giving a free cash flow of -$207.00 million.
| Operating Cash Flow | 14.00M |
| Capital Expenditures | -221.00M |
| Free Cash Flow | -207.00M |
| FCF Per Share | -$0.74 |
Full Cash Flow StatementMargins
Gross margin is 56.76%, with operating and profit margins of -4.26% and -7.31%.
| Gross Margin | 56.76% |
| Operating Margin | -4.26% |
| Pretax Margin | -4.82% |
| Profit Margin | -7.31% |
| EBITDA Margin | 1.00% |
| EBIT Margin | -4.30% |
| FCF Margin | -7.17% |
